Vancomycin dosing in critically ill patients receiving renal replacement therapy: a critical appraisal of the toxicity threshold and external validation - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating Vancomycin Dosage in Critically Ill Patients Undergoing Renal Replacement Therapy: Insights on Toxicity Thresholds and External Validation

  • By

  • Jiaojiao Zhou

  • Haibo Lei

  • Ronghui Li

  • Xiang Liu

  • Guanghui Chen

  • September 22, 2026

Share

Original Source(s)

Vancomycin dosing in critically ill patients receiving renal replacement therapy: a critical appraisal of the toxicity threshold and external validation

  • by Jiaojiao Zhou, Haibo Lei, Ronghui Li, Xiang Liu, Guanghui Chen

  • September 22, 2026

Related Content

Association of baloxavir treatment timing with serial interval and household transmission of influenza through a likelihood-based analysis

How HCPs can help students stay healthy at school

"We are at risk as a nation of losing our measles elimination status."

Nirsevimab may curb RSV severity

Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.